Challenges to the treatment and new perspectives for the eradication of helicobacter pylori

Página do item simplificado
dc.contributor.authorYazbek, Priscila Baptistella [UNESP]
dc.contributor.authorTrindade, Ariane Biolcati [UNESP]
dc.contributor.authorChin, Chung Man [UNESP]
dc.contributor.authorDos Santos, Jean Leandro [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2015-12-07T15:34:39Z
dc.date.available2015-12-07T15:34:39Z
dc.date.issued2015
dc.description.abstractHelicobacter pylori (H. pylori) is one of the leading causes of gastric diseases such as chronic gastritis, peptic ulcer, and gastric adenocarcinoma. The current treatment of H. pylori infection with antibiotics and proton pump inhibitors has several limitations, including poor adherence and intrinsic patient-related factors, drug resistance, and the absence of adequate treatments. This review summarizes the current therapeutic approaches to eradicating H. pylori, the difficulties associated with its treatment, and several new perspectives aimed at improving existing treatment strategies.en
dc.description.affiliationSchool of Pharmaceutical Science, Drugs and Medicines Department, State University of São Paulo Júlio de Mesquita Filho, Rodovia Araraquara Jaú Km, 01 s/n, Araraquara, SP, 14801-902, Brazil.
dc.description.affiliationSchool of Pharmaceutical Science, Drugs and Medicines Department, State University of São Paulo Júlio de Mesquita Filho, Rodovia Araraquara Jaú Km, 01 s/n, Araraquara, SP, 14801-902, Brazil. santosjl@fcfar.unesp.br.
dc.description.affiliationUnespSchool of Pharmaceutical Science, Drugs and Medicines Department, State University of São Paulo Júlio de Mesquita Filho, Rodovia Araraquara Jaú Km, 01 s/n, Araraquara, SP, 14801-902, Brazil.
dc.description.affiliationUnespSchool of Pharmaceutical Science, Drugs and Medicines Department, State University of São Paulo Júlio de Mesquita Filho, Rodovia Araraquara Jaú Km, 01 s/n, Araraquara, SP, 14801-902, Brazil. santosjl@fcfar.unesp.br.
dc.format.extent2901-2912
dc.identifierhttp://dx.doi.org/10.1007/s10620-015-3712-y
dc.identifier.citationDigestive Diseases And Sciences, v. 60, n. 10, p. 2901-2912, 2015.
dc.identifier.doi10.1007/s10620-015-3712-y
dc.identifier.issn1573-2568
dc.identifier.lattes9734333607975413
dc.identifier.orcid0000-0003-4141-0455
dc.identifier.pubmed25999247
dc.identifier.urihttp://hdl.handle.net/11449/131387
dc.language.isoeng
dc.publisherDigestive Diseases And Sciences
dc.relation.ispartofDigestive Diseases And Sciences
dc.relation.ispartofsjr1,330
dc.rights.accessRightsAcesso restrito
dc.sourcePubMed
dc.subjectGastric diseasesen
dc.subjectH. pylori eradicationen
dc.subjectH. pylori resistanceen
dc.subjectHelicobacter pylorien
dc.subjectTreatmenten
dc.titleChallenges to the treatment and new perspectives for the eradication of helicobacter pylorien
dc.typeArtigo
unesp.author.lattes9734333607975413[3]
unesp.author.orcid0000-0003-4141-0455[3]
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos

Coleções

Araraquara - FCF - Faculdade de Ciências Farmacêuticas